Back

Bullish Case: FDA approval of OTC Stelo CGM, partnership with Wave FC, and leading market position suggest continued expansion and adoption, supporting stock growth.


Bearish Case: Insider sales, recent patent litigation loss to Abbott, and emerging competition from Roche may introduce negative sentiment and stock pressure.


Potential Outcomes:

1) 40% FDA approval impact boosts adoption.

2) 30% insider selling leads to stock dip.

3) 20% increased competition affects market share.

4) 10% strategic alliances drive expansion.


Trading Oracle: Sign Up to access trading oracle trade ideas.


April 02, 2024


Dexcom Forecast

DXCM        Dexcom
Price Forecast: BULLISH    Price Action: RANDOM (?)











Correlated Stock Forecasts

Assets that tend to move strongly with DXCM



LPX Forecast + Options Trading Strategies   LPX  Louisiana-Pacific (0.87)


OUT Forecast + Options Trading Strategies   OUT  Outfront Media (0.87)


XYL Forecast + Options Trading Strategies   XYL  Xylem (0.85)


CLDX Forecast + Options Trading Strategies   CLDX  Celldex Therapeutics (0.84)


SQ Forecast + Options Trading Strategies   SQ  Square (0.84)



Uncorrelated Stock Forecasts

Assets with little price relationship to DXCM



APLD Forecast + Options Trading Strategies   APLD  Applied Blockchain (0.0)


AUPH Forecast + Options Trading Strategies   AUPH  Aurinia Pharmaceuticals (-0.0)


FANG Forecast + Options Trading Strategies   FANG  Diamondback Energy (-0.0)


TDC Forecast + Options Trading Strategies   TDC  Teradata (0.01)


HROW Forecast + Options Trading Strategies   HROW  Harrow Health (-0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against DXCM



CANE Forecast + Options Trading Strategies   CANE  Teucrium Sugar (-0.69)


RWM Forecast + Options Trading Strategies   RWM  ProShares Trust - ProShares Short Russell2000 (-0.7)


DRV Forecast + Options Trading Strategies   DRV  Direxion Daily Real Estate Bear 3X Shares (-0.71)


SRS Forecast + Options Trading Strategies   SRS  ProShares UltraShort Real Estate (-0.72)


REK Forecast + Options Trading Strategies   REK  ProShares Short Real Estate (-0.74)





Become a more profitable investor with AI optimized trading strategies






×

Chat with DXCM


 Ask me any question!